Actavis Plc, an Irish-American generic producer, has made an agreed bid to buy Forest Laboratories Inc, a specialty pharmaceutical company, for about $25 billion, comprising 70.9% in stock and 29.1% in cash. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
